Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the area of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and therapy are transforming the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering potential for more effective treatment options.